TrialBMC medicine2013

Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.

Yong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.